The utility of acoustic radiation force impulse (ARFI) imaging for real-time visualization of abdominal malignancies was investigated. Nine patients presenting with suspicious masses in the liver (n = 7) or kidney (n = 2) underwent combined sonography/ARFI imaging. Images were acquired of a total of 12 tumors in the nine patients. In all cases, boundary definition in ARFI images was improved or equivalent to boundary definition in B-mode images. Displacement contrast in ARFI images was superior to echo contrast in B-mode images for each tumor. The mean contrast for suspected hepatocellular carcinomas (HCCs) in B-mode images was 2.9 dB (range: 1.5-4.2) versus 7.5 dB (range: 3.1-11.9) in ARFI images, with all HCCs appearing more compliant than regional cirrhotic liver parenchyma. The mean contrast for metastases in B-mode images was 3.1 dB (range: 1.2-5.2) versus 9.3 dB (range: 5.7-13.9) in ARFI images, with all masses appearing less compliant than regional non-cirrhotic liver parenchyma. ARFI image contrast (10.4 dB) was superior to Bmode contrast (0.9 dB) for a renal mass. To our knowledge, we present the first in vivo images of abdominal malignancies in humans acquired with the ARFI method or any other technique of imaging tissue elasticity.
Background Arrhythmia recurrence after cardiac radiofrequency ablation (RFA) for atrial fibrillation (AF) has been linked to conduction through discontinuous lesion lines. Intraprocedural visualization and corrective ablation of lesion line discontinuities could decrease post-procedure AF recurrence. Intracardiac acoustic radiation force impulse (ARFI) imaging is a new imaging technique that visualizes RFA lesions by mapping the relative elasticity contrast between compliant-unablated and stiff-RFA treated myocardium. Objective To determine if intraprocedure ARFI images can identify RFA treated myocardium in vivo. Methods In eight canines, an electroanatomical mapping (EAM) guided intracardiac echo catheter (ICE) was used to acquire 2D ARFI images along right atrial ablation lines before and after RFA. ARFI images were acquired during diastole with the myocardium positioned at the ARFI focus (1.5 cm) and parallel to the ICE transducer for maximal and uniform energy delivery to the tissue. Three reviewers categorized each ARFI image as depicting no lesion, non-contiguous, or contiguous lesion. For comparison, three separate reviewers confirmed RFA lesion presence and contiguity based on functional conduction block at the imaging plane location on EAM activation maps. Results Ten percent of ARFI images were discarded due to motion artifacts. Reviewers of the ARFI images detected RFA-treated sites with high sensitivity (95.7%) and specificity (91.5%). Reviewer identification of contiguous lesion had 75.3% specificity and 47.1% sensitivity. Conclusions Intracardiac ARFI imaging was successful in identifying endocardial RFA treatment when specific imaging conditions were maintained. Further advances in ARFI imaging technology would facilitate a wider range of imaging opportunities for clinical lesion evaluation.
The initial results from clinical trials investigating the utility of acoustic radiation force impulse (ARFI) imaging for use with radio-frequency ablation (RFA) procedures in the liver are presented. To date, data have been collected from 6 RFA procedures in 5 unique patients. Large displacement contrast was observed in ARFI images of both pre-ablation malignancies (mean 7.5 dB, range 5.7-11.9 dB) and post-ablation thermal lesions (mean 6.2 dB, range 5.1-7.5 dB). In general, ARFI images provided superior boundary definition of structures relative to the use of conventional sonography alone. Although further investigations are required, initial results are encouraging and demonstrate the clinical promise of the ARFI method for use in many stages of RFA procedures.
Ultrasound image quality is often inherently limited by the physical dimensions of the imaging transducer. We hypothesize that, by collecting synthetic aperture data sets over a range of aperture positions while precisely tracking the position and orientation of the transducer, we can synthesize large effective apertures to produce images with improved resolution and target detectability. We analyze the two largest limiting factors for coherent signal summation: aberration and mechanical uncertainty. Using an excised canine abdominal wall as a model phase screen, we experimentally observed an effective arrival time error ranging from 18.3 ns to 58 ns (root-mean-square error) across the swept positions. Through this clutter-generating tissue, we observed a 72.9% improvement in resolution with only a 3.75 dB increase in side lobe amplitude compared to the control case. We present a simulation model to study the effect of calibration and mechanical jitter errors on the synthesized point spread function. The relative effects of these errors in each imaging dimension are explored, showing the importance of orientation relative to the point spread function. We present a prototype device for performing swept synthetic aperture imaging using a conventional 1-D array transducer and ultrasound research scanner. Point target reconstruction error for a 44.2 degree sweep shows a reconstruction precision of 82.8 μm and 17.8 μm in the lateral and axial dimensions respectively, within the acceptable performance bounds of the simulation model. Improvements in resolution, contrast and contrast-to-noise ratio are demonstrated in vivo and in a fetal phantom.
Abstract-A method for rapid measurement of intensities (I spta ), mechanical index (MI), and probe surface temperature for any ultrasound scanning sequence is presented. It uses the scanner's sampling capability to give an accurate measurement of the whole imaging sequence for all emissions to yield the true distributions. The method is several orders of magnitude faster than approaches using an oscilloscope, and it also facilitates validating the emitted pressure field and the scanner's emission sequence software. It has been implemented using the experimental SARUS scanner and the Onda AIMS III intensity measurement system (Onda Corporation, Sunnyvale, CA, USA). Four different sequences have been measured: a fixed focus emission, a duplex sequence containing B-mode and flow emissions, a vector flow sequence with B-mode and flow emissions in 17 directions, and finally a synthetic aperture (SA) duplex flow sequence. A BK8820e (BK Medical, Herlev, Denmark) convex array probe is used for the first three sequences and a BK8670 linear array probe for the SA sequence. The method is shown to give the same intensity values within 0.24% of the AIMS III Soniq 5.0 (Onda Corporation, Sunnyvale, CA, USA) commercial intensity measurement program. The approach can measure and store data for a full imaging sequence in 3.8 to 8.2 s per spatial position. Based on I spta , MI, and probe surface temperature, the method gives the ability to determine whether a sequence is within US FDA limits, or alternatively indicate how to scale it to be within limits.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.